Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer. 2000;89(10):2068–75. https://doi.org/10.1002/1097-0142(20001115)89:10%3c2068::AID-CNCR6%3e3.0.CO;2-Z.

Article  CAS  PubMed  Google Scholar 

Cheeseman IM. The kinetochore. Cold Spring Harb Perspect Biol. 2014;6(7): a015826. https://doi.org/10.1101/cshperspect.a015826.

Article  PubMed  PubMed Central  Google Scholar 

Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene. 2004;23:2016–27. https://doi.org/10.1038/sj.onc.1207374.

Article  CAS  PubMed  Google Scholar 

Ciferri C, De Lucall J, Monzani S, Ferrari KJ, Ristic D, Wyman C, et al. Architecture of the human ndc80-hec1 complex, a critical constituent of the outer kinetochore. J Biol Chem. 2005;280(32):29088–95. https://doi.org/10.1074/jbc.M504070200.

Article  CAS  PubMed  Google Scholar 

Meng QC, Wang HC, Song ZL, Shan ZZ, Yuan Z, Zheng Q, et al. Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. Am J Cancer Res. 2015;5(5):1730–40.

PubMed  PubMed Central  Google Scholar 

Yin H, Meng T, Zhou L, Chen H, Song D. SPC24 is critical for anaplastic thyroid cancer progression. Oncotarget. 2017;8(13):21884–91. https://doi.org/10.18632/oncotarget.15670.

Article  PubMed  PubMed Central  Google Scholar 

Yan X, Huang L, Liu L, Qin H, Song Z. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer. Cancer Med. 2018;7(2):420–32. https://doi.org/10.1002/cam4.1284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Li W, Xiao L, Liu L. Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma. Int J Clin Exp Pathol. 2019;12(4):1233–47.

CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Zhu Y, Li Z, Bu Q, Sun T, Wang H, et al. Up-regulation of SPC25 promotes breast cancer. Aging (Albany NY). 2019;11(15):5689–704. https://doi.org/10.18632/aging.102153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Z-Y, Wang W, Gao H, Chen Q-F. Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adeno-carcinoma. J Cancer. 2020;11(10):2921–34. https://doi.org/10.7150/jca.41834.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, et al. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS ONE. 2012;7(10):1–13. https://doi.org/10.1371/journal.pone.0047086.

Article  CAS  Google Scholar 

Zhou Y, Layton O, Hong L. Identification of genes and pathways involved in ovarian epithelial cancer by bioinformatics analysis. J Cancer. 2018;9(17):3016–22. https://doi.org/10.7150/jca.26133.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong C, Tian X, He F, Zhang J, Cui X, He Q, et al. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics. J Ovarian Res. 2021;14(1):1–12. https://doi.org/10.1186/s13048-021-00837-6.

Article  CAS  Google Scholar 

Jiang X, Jiang Y, Luo S, Sekar K, Koh CKT, Deivasigamani A, et al. Correlation of NUF2 overexpression with poorer patient survival in multiple cancers. Cancer Res Treat. 2021;53(4):944–61. https://doi.org/10.4143/crt.2020.466.

Article  CAS  PubMed  Google Scholar 

Leng R, Meng Y, Sun X, Zhao Y. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes. Front Oncol. 2022;12:1057198. https://doi.org/10.3389/fonc.2022.1057198.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren M, Zhao H, Gao Y, Chen Q, Zhao X, Yue W. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer. J Ovarian Res. 2023;16(1):1–13. https://doi.org/10.1186/s13048-023-01101-9.

Article  CAS  Google Scholar 

Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet. 2014;124(1):1–5. https://doi.org/10.1016/j.ijgo.2013.10.001.

Article  Google Scholar 

Florell SR, Coffin CM, Holden JA, Zimmermann JW, Gerwels JW, Summers BK, et al. Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Mod Pathol. 2001;14(2):116–28. https://doi.org/10.1038/modpathol.3880267.

Article  CAS  PubMed  Google Scholar 

Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532–4, 536–7.

Chen S, Wang X, Zheng S, Li H, Qin S, Liu J, et al. Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer. Exp Ther Med. 2021;22(3):1–13. https://doi.org/10.3892/etm.2021.10355.

Article  CAS  Google Scholar 

Wang W, Zhang W, Hu Y. Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer. PeerJ. 2021;9: e12353. https://doi.org/10.7717/peerj.12353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tayebi-Khorami M, Chegeni N, Tahmasbi-Birgani M, Danyaei A, Fardid R, Zafari J. Enhancement of cisplatin sensitivity by microwave radiation in ovarian cancer cells. Pharm Sci. 2022;28(2):295–303. https://doi.org/10.34172/PS.2021.51.

Article  CAS  Google Scholar 

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134. https://doi.org/10.1186/1471-2105-13-134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. https://doi.org/10.1006/METH.2001.1262.

Article  CAS  PubMed  Google Scholar 

Lánczky A, Győrffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7): e27633. https://doi.org/10.2196/27633.

Article  PubMed  PubMed Central  Google Scholar 

Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–6. https://doi.org/10.1016/j.soncn.2019.02.001.

Article  PubMed  Google Scholar 

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, et al. Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis. Onco Targets Ther. 2018;11:1457–74. https://doi.org/10.2147/OTT.S152238.

Article  PubMed  PubMed Central  Google Scholar 

Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer. 2012;19(6):R255–79. https://doi.org/10.1530/ERC-12-0175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sieh W, Köbel M, Longacre TA, Bowtell DD, DeFazio A, Goodman MT, et al. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol. 2013;14(9):853–62. https://doi.org/10.1016/S1470-2045(13)70253-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo H, Li S, Zhao M, Sheng B, Zhu H, Zhu X. Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis. Oncotarget. 2017;8(22):36845–56. https://doi.org/10.18632/oncotarget.15982.

Article  PubMed  PubMed Central  Google Scholar 

Tan J, Song C, Wang D, Hu Y, Liu D, Ma D, et al. Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer. Biosci Rep. 2021;41(5):BSR20210478. https://doi.org/10.1042/BSR20210478.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Yu Y, Pei Y, Cao C, Ding C, Wang D, et al. A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer. Oncotarget. 2017;8(39):65469–80. https://doi.org/10.18632/oncotarget.18971.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Chen X, Wang J, Zhang P, Han X, Zhang Y, et al. Bioinformatics analysis of prognostic value of SPC24 in ccRCC and Pan-cancer. Int J Gen Med. 2022;15:817–36. https://doi.org/10.2147/IJGM.S348859.

Article  CAS  PubMed